Pharmaceutical Industry Market Reports
In our analytical reports, we cover a wide range of industries and markets in pharma & healthcare. We show you future prospects across a wide range of commercial areas:
- Novel branded pharmaceuticals – therapeutic applications and drug classes
- Biopharmaceuticals (biologics) and healthcare biotechnology, including drug delivery and other technologies
- Generic drugs, the Pharma supply chain and over-the-counter (OTC) medicines
- Outsourced services – clinical trials, Pharma manufacturing and other roles
- Diagnostic tests and instruments
- Medical devices – implants and other products.
You will find revenue forecasts in a Visiongain report. Our reports analyse and explain commercial prospects at overall world, submarket, national and product level, suiting the topics. That way, you assess opportunities and commercial potentials for healthcare industries and markets.
- Access to present and predicted trends, harnessing years of analytical experience and knowledge
- Data and discussions – including our 10-year revenue forecasts – for your research, analyses and decision making
- Tables, charts and lists to benefit your reports, proposals and presentations.
Our studies give you analysis from primary and secondary research. You receive information found only in our work– quantitative and qualitative analyses with independent predictions. Many commercial opportunities exist; we show you where these are and explain their significance and potential from this decade onwards. You can rely on our reports to help you stay ahead.
If you are interested in receiving more information about our reports or have any query, please contact us through our online form.
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Biological Imaging Reagents Market Report 2021-2031
Increasing prevalence of cardiovascular diseases is increasing demand of biological imaging reagents for the diagnosis and treatment of cardiovascular diseases due to this reason increasing prevalence of cardiovascular diseases is acting as a driver for biological imaging reagent market.
13 November 2020
Visiongain Publishes Antihypertensive Drugs Market Report 2021-2031
Hypertensive is the most common disease around the world. However, number of people suffering from hypertensive has increased very significantly from last few years. Hypertensive can occur due to consumption of tobacco, too much salt (sodium) and little potassium in your diet, alcohol and to people being overweight or obese.
13 November 2020
Visiongain Publishes Antibacterial Drugs Market Report 2021-2031
The prevalence of bacterial diseases is significantly growing and expected to continuously rise over the forecast period. Number of bacterial diseases cases are increasing, like, bugs biting, including ticks, mosquitoes, lice and from an infected animal, contaminated food or water.
13 November 2020
Visiongain Publishes Topical Drug Delivery Market Report 2020-2030
Delivery of biologics through the transdermal route is anticipated to open new avenues for the manufacturers of topical drugs. Transdermal route provides appropriate and painless self-administration for patients. It overcomes frequent dosing administration, plasma level instability related to oral dosing and injections to uphold constant drug concentrations, and a drug with a short half-life can be supplied effortlessly.
11 November 2020
